个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Expanding the therapeutic potential of Salvia miltiorrhiza: a review of its pharmacological applications in musculoskeletal diseases

| 认领 | 导出 | |

文献详情

资源类型：
Pubmed体系：
作者：
Ye Zhiqiang[1,2,3] * ; Liu Yuyu[2] * ; Song Jintong[1,2,3] * ; Gao Yin[1,2,4] ; Fang Haiping[2] ; Hu Zilong[2] ; Zhang Min[2] ; Liao Wenwei[2] ; Cui Liao[2] ; Liu Yanzhi[1,2,3] ;
机构： [1]Zhanjiang Key Laboratory of Orthopaedic Technology and Trauma Treatment, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, China. [2]Guangdong Provincial Key Laboratory for Research and Development of Natural Drug, School of Pharmacy, Guangdong Medical University, Zhanjiang, China. [3]Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Infectious Diseases, Guangdong Provincial Administration of Traditional Chinese Medicine (Central People's Hospital of Zhanjiang), Zhanjiang, China. [4]Marine Medical Research Institute of Zhanjiang, Zhanjiang, China.
出处：
DOI： 10.3389/fphar.2023.1276038
ISSN：

关键词： bone joint osteoarthritis osteoporosis Salvia miltiorrhiza musculoskeletal diseases

摘要：
Salvia miltiorrhiz, commonly known as "Danshen" in Chinese medicine, has longstanding history of application in cardiovascular and cerebrovascular diseases. Renowned for its diverse therapeutic properties, including promoting blood circulation, removing blood stasis, calming the mind, tonifying the blood, and benefiting the "Qi", recent studies have revealed its significant positive effects on bone metabolism. This potential has garnered attention for its promising role in treating musculoskeletal disorders. Consequently, there is a high anticipation for a comprehensive review of the potential of Salvia miltiorrhiza in the treatment of various musculoskeletal diseases, effectively introducing an established traditional Chinese medicine into a burgeoning field.Musculoskeletal diseases (MSDs) present significant challenges to healthcare systems worldwide. Previous studies have demonstrated the high efficacy and prospects of Salvia miltiorrhiza and its active ingredients for treatment of MSDs. This review aims to illuminate the newfound applications of Salvia miltiorrhiza and its active ingredients in the treatment of various MSDs, effectively bridging the gap between an established medicine and an emerging field.In this review, previous studies related to Salvia miltiorrhiza and its active ingredients on the treatment of MSD were collected, the specific active ingredients of Salvia miltiorrhiza were summarized, the effects of Salvia miltiorrhiza and its active ingredients for the treatment of MSDs, as well as their potential molecular mechanisms were reviewed and discussed.Based on previous publications, Salvianolic acid A, salvianolic acid B, tanshinone IIA are the representative active ingredients of Salvia miltiorrhiza. Their application has shown significant beneficial outcomes in osteoporosis, fractures, and arthritis. Salvia miltiorrhiza and its active ingredients protect against MSDs by regulating different signaling pathways, including ROS, Wnt, MAPK, and NF-κB signaling.Salvia miltiorrhiza and its active ingredients demonstrate promising potential for bone diseases and have been explored across a wide variety of MSDs. Further exploration of Salvia miltiorrhiza's pharmacological applications in MSDs holds great promise for advancing therapeutic interventions and improving the lives of patients suffering from these diseases.Copyright © 2023 Ye, Liu, Song, Gao, Fang, Hu, Zhang, Liao, Cui and Liu.

基金：
The author(s) declare financial supportwas received for the research, authorship, and/or publication of this article. This research was funded by grants from the National Natural Science Foundation of China (No. 81703584), The regional joint fund of natural science foundation of Guangdong province (No. 2020B1515120052), Guangdong Province Natural Science Foundation of China (No. 2022A1515220166, 2017A030310614, and 2021A1515010975), the Discipline Construction Fund of Central People’s Hospital of Zhanjiang (No. 2022A09), Discipline construction project of Guangdong Medical University (No. 4SG23002G, 4SG21156G, and CLP 2021B012), the Science and Technology Foundation of Zhanjiang (No. 2022A01099), Special Funds for Scientific Technological Innovation of Undergraduates in Guangdong Province (No. pdjh 2022a0214), Guangdong medical university research fund (No. FZZM05).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 2 区 医学
小类 | 2 区 药学
最新[2025]版：
大类 | 3 区 医学
小类 | 3 区 药学
第一作者：
第一作者机构： [1]Zhanjiang Key Laboratory of Orthopaedic Technology and Trauma Treatment, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, China. [2]Guangdong Provincial Key Laboratory for Research and Development of Natural Drug, School of Pharmacy, Guangdong Medical University, Zhanjiang, China. [3]Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Infectious Diseases, Guangdong Provincial Administration of Traditional Chinese Medicine (Central People's Hospital of Zhanjiang), Zhanjiang, China.
共同第一作者：
通讯作者：
通讯机构： [1]Zhanjiang Key Laboratory of Orthopaedic Technology and Trauma Treatment, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, China. [2]Guangdong Provincial Key Laboratory for Research and Development of Natural Drug, School of Pharmacy, Guangdong Medical University, Zhanjiang, China. [3]Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Infectious Diseases, Guangdong Provincial Administration of Traditional Chinese Medicine (Central People's Hospital of Zhanjiang), Zhanjiang, China.
推荐引用方式(GB/T 7714)：
Ye Zhiqiang,Liu Yuyu,Song Jintong,et al.Expanding the therapeutic potential of Salvia miltiorrhiza: a review of its pharmacological applications in musculoskeletal diseases[J].Frontiers In Pharmacology.2023,14:1276038.doi:10.3389/fphar.2023.1276038.
APA：
Ye Zhiqiang,Liu Yuyu,Song Jintong,Gao Yin,Fang Haiping...&Liu Yanzhi.(2023).Expanding the therapeutic potential of Salvia miltiorrhiza: a review of its pharmacological applications in musculoskeletal diseases.Frontiers In Pharmacology,14,
MLA：
Ye Zhiqiang,et al."Expanding the therapeutic potential of Salvia miltiorrhiza: a review of its pharmacological applications in musculoskeletal diseases".Frontiers In Pharmacology 14.(2023):1276038

相关文献

[1]膝骨性关节炎患者膝关节局部骨密度的差异性研究 [2]Efficacy and safety of the orthopaedic manipulation techniques of the Lin School of Lingnan Region in the treatment of adolescent idiopathic scoliosis: protocol of a participant-and-assessor-blinded randomized controlled study [3]丹参注射液通过诱导自噬抑制足细胞凋亡的研究 [4]眼部低温脉冲离子导入模式治疗糖尿病性视网膜病变的疗效 [5]丹参干预骨质疏松症：网络药理学解释的作用机制 [6]丹参干预骨质疏松症:网络药理学解释的作用机制 [7]丹参诱导骨髓基质细胞神经元样细胞分化的microRNA-128路径 [8]Longbie capsules reduce bone loss in the subchondral bone of rats with comorbid osteoporosis and osteoarthritis by regulating metabolite alterations [9]Guidelines for the diagnosis and treatment of knee osteoarthritis with integrative medicine based on traditional Chinese medicine [10]Neuroprotection against Aβ25-35-induced apoptosis by Salvia miltiorrhiza extract in SH-SY5Y cells.

资源点击量：2027 今日访问量：0 总访问量：659 更新日期：2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持：重庆聚合科技有限公司 地址：广州市越秀区大德路111号